Here are some of the recent top stories on Healio.com/OSN:
Xelpros gains FDA approval for open-angle glaucoma, ocular hypertension
Xelpros (latanoprost ophthalmic solution 0.005%) is the first latanoprost product not formulated with the preservative benzalkonium chloride and was developed with SPARC’s Swollen Micelle Microemulsion technology. Read more.
Risk score may help identify schoolchildren at high risk for myopia
A newly developed risk score that combines environmental and ocular factors may help identify schoolchildren who are at high risk for myopia. Read more.
Uncategorized